Results 111 to 120 of about 72,402 (211)

BRCA1 regulation of breast cancer cell motility

open access: yes
Breast cancer remains a leading cause of cancer-related mortality globally, generating a need for a deeper understanding of the molecular mechanisms driving its progression. The protein product of BRCA1, a crucial tumour suppressor gene, has emerged as a
Hernandez Nuñez, Zayra
core   +1 more source

Clinical follow up of Mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes Estudio de seguimiento clínico de mujeres mexicanas con cáncer de mama de inicio temprano y mutaciones en los genes BRCA1 y BRCA2

open access: yesSalud Pública de México, 2005
OBJECTIVE: This study describes the presence of mutations in BRCA1 and BRCA2 genes in a group of Mexican women and the clinical evolution of early onset breast cancer (EOBC).
Ana Laura Calderón-Garcidueñas   +3 more
doaj  

Implication of BRCA1 gene in breast cancer.

open access: yesIndian journal of experimental biology, 2001
Breast cancer susceptibility gene (BRCA1) is known to be responsible for hereditary breast and ovarian cancer. This gene is highly penetrant conferring a risk for 0.92 by the age of 70. Germline mutation in this gene leads to susceptibility to breast and ovarian cancer, with a genotype phenotype correlation.
S K, Kachhap, S N, Ghosh
openaire   +1 more source

Evaluation of healthcare management issues in the provision of clinical services for familial breast/ovarian cancer

open access: yes, 2009
Electronic version does not contain associated previously published materialDespite there being pragmatic national guidelines for assigning risk to women with a family history of breast cancer, the evidence base is still sparse.
de Azevedo Moreira Reis, Marta
core  

Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer

open access: yes
Although BRCA genes are well-known breast cancer genes, the clinicopathological features of breast cancer patients carrying BRCA1/2 pathogenic variants have not been adequately defined.
Nazan Eras   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy